Your browser doesn't support javascript.
loading
Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).
Eriksson, Carl; Marsal, Jan; Bergemalm, Daniel; Vigren, Lina; Björk, Jan; Eberhardson, Michael; Karling, Pontus; Söderman, Charlotte; Myrelid, Pär; Cao, Yang; Sjöberg, Daniel; Thörn, Mari; Karlén, Per; Hertervig, Erik; Strid, Hans; Ludvigsson, Jonas F; Almer, Sven; Halfvarson, Jonas.
Afiliación
  • Eriksson C; a Department of Gastroenterology, Faculty of Medicine and Health , Örebro University , Örebro , Sweden.
  • Marsal J; b Immunology Section , Lund University , Lund , Sweden.
  • Bergemalm D; c Department of Gastroenterology , Skåne University Hospital , Lund , Sweden.
  • Vigren L; a Department of Gastroenterology, Faculty of Medicine and Health , Örebro University , Örebro , Sweden.
  • Björk J; d Department of Internal Medicine , Ystad Hospital , Ystad , Sweden.
  • Eberhardson M; e Department of Medicine , Center for Digestive Diseases, Karolinska University Hospital , Karolinska Institutet , Solna , Stockholm , Sweden.
  • Karling P; e Department of Medicine , Center for Digestive Diseases, Karolinska University Hospital , Karolinska Institutet , Solna , Stockholm , Sweden.
  • Söderman C; f Department of Public Health and Clinical Medicine , Umeå University , Umeå , Sweden.
  • Cao Y; h Department of Clinical and Experimental Medicine, Linköping University and Department of Surgery , Linköping University Hospital , Linköping , Sweden.
  • Sjöberg D; i Department of Clinical Epidemiology and Biostatistics, School of Medical Sciences , Örebro University , Örebro , Sweden.
  • Thörn M; j Department of Medical Epidemiology and Biostatistics , Karolinska Institutet , Stockholm , Sweden.
  • Karlén P; k Center for Clinical Research Dalarna , Uppsala University , Falun , Sweden.
  • Hertervig E; l Department of Medical Sciences, Section of Gastroenterology and Hepatology , Uppsala University , Uppsala , Sweden.
  • Strid H; m Department of Internal Medicine , Danderyd Hospital , Stockholm , Sweden.
  • Ludvigsson JF; c Department of Gastroenterology , Skåne University Hospital , Lund , Sweden.
  • Almer S; n Department of Internal Medicine , Södra Älvsborgs Sjukhus , Borås , Sweden.
  • Halfvarson J; j Department of Medical Epidemiology and Biostatistics , Karolinska Institutet , Stockholm , Sweden.
Scand J Gastroenterol ; 52(6-7): 722-729, 2017.
Article en En | MEDLINE | ID: mdl-28362144
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Enfermedad de Crohn / Factor de Necrosis Tumoral alfa / Anticuerpos Monoclonales Humanizados Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Scand J Gastroenterol Año: 2017 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Enfermedad de Crohn / Factor de Necrosis Tumoral alfa / Anticuerpos Monoclonales Humanizados Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Scand J Gastroenterol Año: 2017 Tipo del documento: Article País de afiliación: Suecia